T Scott Stroup

Generating comparative evidence on new drugs and devices before approval

Andrea Cipriani, Georgia Salanti, Huseyin Naci, 2020, The Lancet.

Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs

Jianxin Shi, Susmita Datta, Aribert Rothenberger, 2013, Nature Genetics.

Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.

Daniel Weintraub, Jeffrey A Lieberman, Pierre N Tariot, 2006, The New England journal of medicine.

Schizophrenia, Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and number needed to treat: how can CATIE inform clinicians?

L. Citrome, T Scott Stroup, L Citrome, 2006, International journal of clinical practice.

Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD.

Wendy J Mack, Pierre N Tariot, Mary Sano, 2011, The American journal of psychiatry.

Genome-Wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia

Jeffrey A Lieberman, Patrick F Sullivan, Robert E Vann, 2011, Neuropsychopharmacology.

Time to All-Cause Treatment Discontinuation as the Primary Outcome in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Study

Jeffrey A Lieberman, Gary G Koch, Robert A Rosenheck, 2011, Statistics in biopharmaceutical research.